Olympia, Arnies son Joseph Baena trains under Leo Mayrhofer, who hails from Austria
Rather than daily injections, the protocol requires a heavier 2.5 mg systemic dose injected twice per week
Building on the success of tirzepatidethe first approved dual GLP-1/GIP co-agonistother dual agonists, including those targeting both GLP-1 and GCG receptors, are in an advanced stage of development
This combination is not FDA-approved and has not been tested in clinical trials for its safety and efficacy
Summary: B12 injections do not promote fat loss in individuals with normal vitamin B12 levels and are not clinically indicated for weight management purposes
Preclinical work suggests BPC-157 upregulates vascular endothelial growth factor receptor 2 (VEGFR2) and modulates the nitric oxide (NO) system, both of which are central to delivering oxygen and nutrients to healing tissue